Your browser doesn't support javascript.
loading
Pyruvate carboxylase deficiency type A and type C: Characterization of five novel pathogenic variants in PC and analysis of the genotype-phenotype correlation.
Coci, Emanuele G; Gapsys, Vytautas; Shur, Natasha; Shin-Podskarbi, Yoon; de Groot, Bert L; Miller, Kathryn; Vockley, Jerry; Sondheimer, Neal; Ganetzky, Rebecca; Freisinger, Peter.
Afiliação
  • Coci EG; Department for Neuropediatrics, University Children's Hospital, Ruhr University Bochum, Bochum, Germany.
  • Gapsys V; Institute for Neuropediatrics and Social Pediatrics, Hamburg, Germany.
  • Shur N; Computational Biomolecular Dynamics Group, Max Plank Institute for Biophysical Chemistry, Göttingen, Germany.
  • Shin-Podskarbi Y; Division of Genetics, Albany Medical Center, Albany, New York.
  • de Groot BL; Children's National Medical Center, Washington, District of Columbia.
  • Miller K; Molecular Genetics and Metabolism Laboratory, Munich, Germany.
  • Vockley J; Computational Biomolecular Dynamics Group, Max Plank Institute for Biophysical Chemistry, Göttingen, Germany.
  • Sondheimer N; Division of Genetics, Albany Medical Center, Albany, New York.
  • Ganetzky R; Children's Hospital of Pittsburgh, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.
  • Freisinger P; Clinical and Metabolic Genetics, The Hospital for Sick Children, Toronto, Ontario, Canada.
Hum Mutat ; 40(6): 816-827, 2019 06.
Article em En | MEDLINE | ID: mdl-30870574
ABSTRACT
Pyruvate carboxylase deficiency (PCD) is caused by biallelic mutations of the PC gene. The reported clinical spectrum includes a neonatal form with early death (type B), an infantile fatal form (type A), and a late-onset form with isolated mild intellectual delay (type C). Apart from homozygous stop-codon mutations leading to type B PCD, a genotype-phenotype correlation has not otherwise been discernible. Indeed, patients harboring biallelic heterozygous variants leading to PC activity near zero can present either with a fatal infantile type A or with a benign late onset type C form. In this study, we analyzed six novel patients with type A (three) and type C (three) PCD, and compared them with previously reported cases. First, we observed that type C PCD is not associated to homozygous variants in PC. In silico modeling was used to map former and novel variants associated to type A and C PCD, and to predict their potential effects on the enzyme structure and function. We found that variants lead to type A or type C phenotype based on the destabilization between the two major enzyme conformers. In general, our study on novel and previously reported patients improves the overall understanding on type A and C PCD.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Piruvato Carboxilase / Doença da Deficiência de Piruvato Carboxilase / Mutação Tipo de estudo: Prognostic_studies Limite: Child / Child, preschool / Female / Humans / Infant / Male Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Piruvato Carboxilase / Doença da Deficiência de Piruvato Carboxilase / Mutação Tipo de estudo: Prognostic_studies Limite: Child / Child, preschool / Female / Humans / Infant / Male Idioma: En Ano de publicação: 2019 Tipo de documento: Article